After a busy holiday season, many of us start the new year wondering what we can do to resolve our reflux. Overindulgence in food and drink during prolonged periods of sitting can backfire with heartburn and other reflux related symptoms.
As we come together this month to celebrate National COPD Awareness and World COPD Day, it’s worth remembering the complexities that COPD (Chronic Obstructive Pulmonary Disorder) can bring to other diagnoses, especially GERD (Gastro-Esophageal Reflux Disease) and LPR (Laryngo-Pharyngeal Reflux).
A new study on Stretta anti-reflux therapy was recently published in Frontline Gastroenterology, reinforcing the value and safety of Stretta as a viable option for many patients who are unwilling or unable to undergo surgical intervention.
University of Kansas Voice and Swallow Center Director, David Garnett MD, FACS delivers keynote presentation in China: "Hyperacidity and the Irritated Airway"
Andrew Krauss, MS, CCC-SLP is heading to Philly to represent Restech at the Voice Foundation's Annual Symposium. This meeting is an intimate gathering of voice professionals, researchers, and students in otolaryngology, voice science, speech pathology and vocal pedagogy. Restech has supported the meeting for the past decade and we are excited to be there again this year.
Dr. Josef Schlömicher-Thier
Chief of the International Voice Center Austria
Chief of the ENT Center in Neumarkt/Salzburg
CASE HISTORY & EVALUATION
A 60 year old male presented with hoarseness, a heavy cough, and voice problems extending back at least four years. Symptoms had recently exacerbated leaving the individual out of work on sick leave. The patient reported multiple prior pneumonias, but presented with a normal pulmonary exam at the time of the initial assessment.
Prior to his office assessment, the patient was examined at a different hospital. This included the discovery of a minor hiatal hernia, which was accompanied by a negative esophageal manometry test and a negative duel channel pH test. Video Stroboscopy revealed hyperplasia/ leucoplakia. VRP showed a restricted mass.
Houston, TX, 04/24/18: Respiratory Technology Corporation (Restech) announced today the asset acquisition of Mederi Therapeutics Inc. In response to the increasing need for therapeutic options to address the growing conditions of reflux disease and gastric disease, Restech welcomes the addition Stretta® and Secca® technology to their product portfolio. These new innovative product lines complement Restech’s existing diagnostic devices with therapeutic solutions, provide additional clinical pathways, and broaden Restech’s global distribution network.
Commonly referred to as “silent reflux,” laryngopharyngeal reflux (LPR) has long been difficult for physicians to diagnose because of its nonspecific symptoms. The traditional approach to assessing LPR symptoms relies on response to empiric treatment and symptom improvement using the reflux symptom index (RSI) or reflux finding score (RFS). Without clear criteria in place, these tools are highly subjective.
By: Craig H. Zalvan, MD, FACS
Chief of Otolaryngology and Medical Director
The Institute for Voice and Swallowing Disorders
CASE HISTORY & EVALUATION
66 year old male presents with diagnosis of GERD and asthma for chronic cough. He reports being well until 5 years ago when he had a severe URI, symptoms of which resolved, except for a chronic cough. Additional symptoms of ongoing waterbrash, throat clearing, and globus sensation; a tickle sensation in the throat followed by spasms of coughing associated with bouts of “wheezing,” described as a high pitch sound when breathing inward. He also reports his eyes tearing, rhinorrhea, and vocal strain with occasional bouts of nausea. Cold air and talking trigger coughing episodes.